These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28455911)

  • 1. Concentrated Sodium Citrate (23%) for Catheter Lock.
    Ash SR; Mankus RA; Sutton JM; Criswell RE; Crull CC; Velasquez KA; Smeltzer BD; Ing TS
    Hemodial Int; 2000 Jan; 4(1):22-31. PubMed ID: 28455911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
    Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
    Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
    Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence and costs of bacteremia due to lack of gentamicin lock solutions for dialysis catheters.
    Goh TL; Wei J; Semple D; Collins J
    Nephrology (Carlton); 2017 Jun; 22(6):485-489. PubMed ID: 28429519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
    Yon CK; Low CL
    Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic lock: in vitro stability of gentamicin and sodium citrate stored in dialysis catheters at 37 degrees C.
    Battistella M; Vercaigne LM; Cote D; Lok CE
    Hemodial Int; 2010 Jul; 14(3):322-6. PubMed ID: 20345391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
    Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
    Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients: a systematic review and network meta-analysis.
    Sheng KX; Zhang P; Li JW; Cheng J; He YC; Böhlke M; Chen JH
    Clin Microbiol Infect; 2020 May; 26(5):545-552. PubMed ID: 31857208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.
    Moran JE; Ash SR;
    Semin Dial; 2008; 21(5):490-2. PubMed ID: 18764795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces.
    Shanks RM; Sargent JL; Martinez RM; Graber ML; O'Toole GA
    Nephrol Dial Transplant; 2006 Aug; 21(8):2247-55. PubMed ID: 16627606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium citrate 4% locking solution for central venous dialysis catheters--an effective, more cost-efficient alternative to heparin.
    Grudzinski L; Quinan P; Kwok S; Pierratos A
    Nephrol Dial Transplant; 2007 Feb; 22(2):471-6. PubMed ID: 17065193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
    Betjes MG; van Agteren M
    Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic lock solutions for the prevention of catheter-related bacteraemia in haemodialysis patients.
    Chow KM; Poon YL; Lam MP; Poon KL; Szeto CC; Li PK
    Hong Kong Med J; 2010 Aug; 16(4):269-74. PubMed ID: 20683069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant therapies versus heparin for the prevention of hemodialysis catheter-related complications: systematic review and meta-analysis of prospective randomized controlled trials.
    Liu J; Wang C; Zhao H; Zhang J; Ma J; Hou Y; Zou H
    Int J Clin Exp Med; 2015; 8(8):11985-95. PubMed ID: 26550111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients.
    Zwiech R; Adelt M; Chrul S
    Am J Ther; 2016; 23(2):e363-8. PubMed ID: 23665885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Concentration Trisodium Citrate as a Non-inferior Locking Agent for Non-tunneled Dialysis Catheters in the Asian Setting.
    Jayaprakash V; Jagadeswaran D; Ezhilmathi K; Sathiapriya A; Vamsikrishna M; Indhumathi E; Jayakumar M
    Indian J Nephrol; 2019; 29(6):410-414. PubMed ID: 31798223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7% sodium citrate (with benzyl alcohol) as catheter lock: Dedication or obsession?
    Ash SR
    Artif Organs; 2022 Dec; 46(12):2500-2503. PubMed ID: 36309942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial.
    Kanaa M; Wright MJ; Akbani H; Laboi P; Bhandari S; Sandoe JA
    Am J Kidney Dis; 2015 Dec; 66(6):1015-23. PubMed ID: 26141306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrated sodium citrate catheter lock: "The best laid schemes o' mice an' men…".
    Ash SR
    Artif Organs; 2022 Aug; 46(8):1701-1704. PubMed ID: 35733080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reevaluation of lock solutions for Central venous catheters in hemodialysis: a narrative review.
    Wang Y; Sun X
    Ren Fail; 2022 Dec; 44(1):1501-1518. PubMed ID: 36047812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.